1. Home
  2. MBIO vs MNDR Comparison

MBIO vs MNDR Comparison

Compare MBIO & MNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • MNDR
  • Stock Information
  • Founded
  • MBIO 2015
  • MNDR 2016
  • Country
  • MBIO United States
  • MNDR Singapore
  • Employees
  • MBIO N/A
  • MNDR N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • MNDR
  • Sector
  • MBIO Health Care
  • MNDR
  • Exchange
  • MBIO Nasdaq
  • MNDR Nasdaq
  • Market Cap
  • MBIO 9.1M
  • MNDR 10.1M
  • IPO Year
  • MBIO N/A
  • MNDR 2024
  • Fundamental
  • Price
  • MBIO $0.18
  • MNDR $0.32
  • Analyst Decision
  • MBIO Strong Buy
  • MNDR
  • Analyst Count
  • MBIO 1
  • MNDR 0
  • Target Price
  • MBIO $2.00
  • MNDR N/A
  • AVG Volume (30 Days)
  • MBIO 659.9K
  • MNDR 461.9K
  • Earning Date
  • MBIO 11-08-2024
  • MNDR 02-16-2025
  • Dividend Yield
  • MBIO N/A
  • MNDR N/A
  • EPS Growth
  • MBIO N/A
  • MNDR N/A
  • EPS
  • MBIO N/A
  • MNDR N/A
  • Revenue
  • MBIO N/A
  • MNDR $13,968,535.00
  • Revenue This Year
  • MBIO N/A
  • MNDR $188,831.77
  • Revenue Next Year
  • MBIO N/A
  • MNDR $76.44
  • P/E Ratio
  • MBIO N/A
  • MNDR N/A
  • Revenue Growth
  • MBIO N/A
  • MNDR 77.38
  • 52 Week Low
  • MBIO $0.13
  • MNDR $0.23
  • 52 Week High
  • MBIO $1.53
  • MNDR $29.50
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 45.42
  • MNDR N/A
  • Support Level
  • MBIO $0.16
  • MNDR N/A
  • Resistance Level
  • MBIO $0.18
  • MNDR N/A
  • Average True Range (ATR)
  • MBIO 0.02
  • MNDR 0.00
  • MACD
  • MBIO 0.00
  • MNDR 0.00
  • Stochastic Oscillator
  • MBIO 55.37
  • MNDR 0.00

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.

Share on Social Networks: